PATIENTS (PTS) WITH RECURRENT GYNECOLOGIC CANCER WHOSE TUMORS HAVE ACTIVATING WNT PATHWAY MUTATIONS RESPOND BETTER TO DKN-01, A DICKKOPF-1 (DKK1) INHIBITOR

Arend, R; Castro, C; Matulonis, U; Hamilton, E; Gunderson, C; LyBarger, K; Goodman, H; Duska, L; Mahdi, H; ElNaggar, A; Kagey, M; Barroilhet, L; Bradley, W; Sachdev, J; O'Malley, D; Sirard, C; Birrer, M

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019; 29 (): A40